臨床薬理の進歩 No.43
46/233

文  献9)Zhang Y, Xu L, Hu Y, Wu J, Li C, Wang J, et al. Functional connectivity between sensory-motor subnetworks reflects the duration of untreated psychosis and predicts treatment outcome of first-episode drug-naïve schizophrenia. Biol Psychiatry Cogn Neurosci Neuroimaging 2019; 4: 697-705.10)Li H, Ou Y, Liu F, Chen J, Zhao J, Guo W, et al. Reduced connectivity in anterior cingulate cortex as an early predictor for treatment response in drug-naive, first-episode schizophrenia: A global-brain functional connectivity analysis. Schizophr Res 2020; 215: 337-43.11)Maximo JO, Kraguljac NV, Rountree BG, Lahti AC. Structural and functional default mode network connectivity and antipsychotic treatment response in medication-naïve first episode psychosis patients. Schizophr Bull Open 2021; 2: sgab032.12)Brakowski J, Spinelli S, Dörig N, Bosch OG, Manoliu A, Holtforth MG, et al. Resting state brain network function in major depression – Depression symptomatology, antidepressant treatment effects, future research. J Psychiatr Res 2017; 92: 147-59.13)Dunlop K, Talishinsky A, Liston C. Intrinsic brain network biomarkers of antidepressant response: a review. Curr Psychiatry Rep 2019; 21: 87.14)Conio B, Martino M, Magioncalda P, Escelsior A, Inglese M, Amore M, et al. Opposite effects of dopamine and serotonin on resting-state networks: review and implications for psychiatric disorders. Mol Psychiatry 2020; 25: 82-93.15)Lee J, Pavuluri MN, Kim JH, Suh S, Kim I, Lee MS. Resting-state functional connectivity in medication-naïve adolescents with major depressive disorder. Psychiatry Res Neuroimaging 2019; 288: 37-43.321)Wang L, Xia M, Li K, Zeng Y, Su Y, Dai W, et al. The effects of antidepressant treatment on resting-state functional brain networks in patients with major depressive disorder. Hum Brain Mapp 2015; 36: 768-78.2)Hu ML, Zong XF, Zheng JJ, Pantazatos SP, Miller JM, Li ZC, et al. Short-term effects of risperidone monotherapy on spontaneous brain activity in first-episode treatment-naïve schizophrenia patients: a longitudinal fMRI study. Sci Rep 2016; 6: 34287.3)Li L, Su YA, Wu YK, Castellanos FX, Li K, Li JT, et al. Eight-week antidepressant treatment reduces functional connectivity in first-episode drug-naïve patients with major depressive disorder. Hum Brain Mapp 2021; 42: 2593-605.4)Cao B, Cho RY, Chen D, Xiu M, Wang L, Soares JC, et al. Treatment response prediction and individualized identification of first-episode drug-naïve schizophrenia using brain functional connectivity. Mol Psychiatry 2020; 25: 906-13.5)Wylie KP, Smucny J, Legget KT, Tregellas JR. Targeting functional biomarkers in schizophrenia with neuroimaging. Curr Pharm Des 2016; 22: 2117-23.6)Andreasen NC, Carpenter WT, Jr., Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005; 162: 441-9.7)Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991; 48: 851-5.8)Peng Y, Zhang S, Zhou Y, Song Y, Yang G, Hao K, et al. Abnormal functional connectivity based on nodes of the default mode network in first-episode drug-naive early-onset schizophrenia. Psychiatry Res 2021; 295: 113578.

元のページ  ../index.html#46

このブックを見る